<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Carboprost – Drug Information</title>
  <style>
    :root {
      --primary: #145da0;
      --primary-light: #e3f2fd;
      --accent: #f39c12;
      --danger: #c0392b;
      --bg: #f7f9fc;
      --card-bg: #ffffff;
      --text-main: #202630;
      --text-muted: #6b7280;
      --border-soft: #e0e6f0;
    }

    * {
      box-sizing: border-box;
      margin: 0;
      padding: 0;
    }

    body {
      font-family: system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;
      background: radial-gradient(circle at top left, #e3f2fd, #f7f9fc 45%, #ffffff 80%);
      color: var(--text-main);
      line-height: 1.6;
      padding: 16px;
    }

    .page {
      max-width: 960px;
      margin: 0 auto;
    }

    header {
      background: linear-gradient(135deg, var(--primary), #0e3d6f);
      color: white;
      padding: 20px 20px 18px;
      border-radius: 16px;
      box-shadow: 0 14px 40px rgba(0, 0, 0, 0.15);
      margin-bottom: 20px;
    }

    .drug-name {
      font-size: 2rem;
      font-weight: 700;
      letter-spacing: 0.03em;
      text-transform: uppercase;
      margin-bottom: 6px;
    }

    .subtitle {
      font-size: 0.95rem;
      opacity: 0.9;
    }

    .tag-row {
      margin-top: 12px;
      display: flex;
      flex-wrap: wrap;
      gap: 8px;
    }

    .tag {
      font-size: 0.8rem;
      border-radius: 999px;
      padding: 4px 10px;
      border: 1px solid rgba(255, 255, 255, 0.5);
      background: rgba(255, 255, 255, 0.08);
      backdrop-filter: blur(4px);
      white-space: nowrap;
    }

    /* NEW: style for the infographic image */
    .header-image {
      margin-top: 16px;
      width: 100%;
      max-height: 380px;
      object-fit: contain;
      border-radius: 12px;
      background: white;
      padding: 10px;
    }

    .layout {
      display: grid;
      grid-template-columns: minmax(0, 3fr) minmax(0, 2.2fr);
      gap: 16px;
      margin-bottom: 16px;
    }

    @media (max-width: 768px) {
      .layout {
        grid-template-columns: 1fr;
      }
      header {
        padding: 16px 14px;
      }
      .drug-name {
        font-size: 1.6rem;
      }
    }

    section {
      margin-bottom: 16px;
    }

    .card {
      background: var(--card-bg);
      border-radius: 14px;
      padding: 16px;
      box-shadow: 0 4px 18px rgba(15, 23, 42, 0.05);
      border: 1px solid var(--border-soft);
    }

    .card-header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      margin-bottom: 8px;
      gap: 8px;
    }

    .card-title {
      font-size: 1rem;
      font-weight: 600;
      text-transform: uppercase;
      letter-spacing: 0.07em;
      color: var(--primary);
    }

    .pill {
      font-size: 0.75rem;
      padding: 3px 9px;
      border-radius: 999px;
      background: var(--primary-light);
      color: var(--primary);
      font-weight: 500;
      white-space: nowrap;
    }

    .dose-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
      gap: 8px;
      margin-top: 4px;
    }

    .dose-item {
      padding: 10px 12px;
      border-radius: 10px;
      background: #f9fafb;
      border: 1px dashed #d4dde9;
    }

    .dose-label {
      font-size: 0.75rem;
      text-transform: uppercase;
      letter-spacing: 0.08em;
      color: var(--text-muted);
      margin-bottom: 2px;
    }

    .dose-value {
      font-size: 0.95rem;
      font-weight: 600;
    }

    ul {
      list-style: none;
      display: grid;
      gap: 6px;
      margin-top: 4px;
    }

    li {
      font-size: 0.92rem;
      position: relative;
      padding-left: 18px;
    }

    li::before {
      content: "•";
      position: absolute;
      left: 4px;
      top: 0;
      color: var(--accent);
      font-weight: 900;
    }

    .note {
      font-size: 0.8rem;
      color: var(--text-muted);
      margin-top: 6px;
    }

    .two-column {
      display: grid;
      grid-template-columns: minmax(0, 1.3fr) minmax(0, 1fr);
      gap: 12px;
    }

    @media (max-width: 768px) {
      .two-column {
        grid-template-columns: 1fr;
      }
    }

    .badge-list {
      display: flex;
      flex-wrap: wrap;
      gap: 6px;
      margin-top: 6px;
    }

    .badge {
      font-size: 0.8rem;
      padding: 4px 10px;
      border-radius: 999px;
      background: #f3f4f6;
    }

    .badge.danger {
      background: #fee2e2;
      color: var(--danger);
      font-weight: 500;
    }

    .interaction-list li::before {
      color: var(--primary);
    }

    .adr-columns {
      display: grid;
      grid-template-columns: minmax(0, 1fr) minmax(0, 1fr);
      gap: 10px;
    }

    @media (max-width: 768px) {
      .adr-columns {
        grid-template-columns: 1fr;
      }
    }

    .chip-title {
      font-size: 0.8rem;
      font-weight: 600;
      text-transform: uppercase;
      letter-spacing: 0.1em;
      margin-bottom: 4px;
    }

    .chip-title.danger {
      color: var(--danger);
    }

    .warning-strip {
      margin-top: 8px;
      padding: 8px 10px;
      border-radius: 10px;
      background: #fef2f2;
      border: 1px solid #fecaca;
      font-size: 0.85rem;
      display: flex;
      gap: 8px;
      align-items: flex-start;
    }

    .warning-icon {
      font-size: 1rem;
      line-height: 1;
      margin-top: 1px;
    }

    footer {
      font-size: 0.74rem;
      color: var(--text-muted);
      text-align: center;
      margin-top: 8px;
      padding: 8px 0 4px;
    }
  </style>
</head>
<body>
  <div class="page">

    <!-- HEADER / TITLE -->
    <header>
      <div class="drug-name">Carboprost</div>
      <div class="subtitle">
        Prostaglandin F<sub>2α</sub> analogue · Uterotonic agent
      </div>
      <div class="tag-row">
        <span class="tag">Class: Prostaglandin analogue</span>
        <span class="tag">Sub-class: PGF<sub>2α</sub> analogue</span>
        <span class="tag">Route: Deep IM injection</span>
        <span class="tag">Used in: PPH · 2nd-trimester termination</span>
      </div>

      <!-- NEW: infographic image -->
      <img
        src="carboprost.png.jpeg"
        alt="Carboprost Tromethamine clinical snapshot infographic"
        class="header-image"
      >
    </header>

    <!-- TOP LAYOUT: DOSE + INDICATIONS -->
    <div class="layout">

      <!-- DOSE & ROUTE -->
      <section class="card">
        <div class="card-header">
          <h2 class="card-title">Dose & Route</h2>
          <span class="pill">Standard Regimen</span>
        </div>
        <div class="dose-grid">
          <div class="dose-item">
            <div class="dose-label">Single dose</div>
            <div class="dose-value">250 micrograms (0.25 mg)</div>
          </div>
          <div class="dose-item">
            <div class="dose-label">Route</div>
            <div class="dose-value">Deep intramuscular (IM) injection</div>
          </div>
          <div class="dose-item">
            <div class="dose-label">Repeat</div>
            <div class="dose-value">Every 15–90 minutes</div>
          </div>
          <div class="dose-item">
            <div class="dose-label">Maximum</div>
            <div class="dose-value">
              Up to 8 doses (total max 2 mg)
            </div>
          </div>
        </div>
        <p class="note">
          *Dosing must always be individualized and used under specialist supervision in a hospital setting.
        </p>
      </section>

      <!-- INDICATIONS -->
      <section class="card">
        <div class="card-header">
          <h2 class="card-title">Indications</h2>
          <span class="pill">Obstetric Uses</span>
        </div>
        <ul>
          <li>
            <strong>Postpartum hemorrhage (PPH)</strong> due to uterine atony  
            <span class="note">(after failure of oxytocin and ergometrine)</span>
          </li>
          <li>
            <strong>Second-trimester medical abortion</strong> (≥13 weeks)  
            – for induction or expulsion
          </li>
          <li>
            <strong>Evacuation of retained products of conception (RPOC)</strong> in mid-trimester
          </li>
          <li>
            <strong>Termination in missed / incomplete abortion</strong> (mid-trimester)
          </li>
        </ul>
      </section>
    </div>

    <!-- MECHANISM + KEY EFFECTS -->
    <section class="card">
      <div class="card-header">
        <h2 class="card-title">Mechanism of Action</h2>
        <span class="pill">PGF<sub>2α</sub> Receptor Agonist</span>
      </div>
      <div class="two-column">
        <div>
          <p>
            Carboprost is a synthetic analogue of prostaglandin F<sub>2α</sub> that binds to
            prostaglandin F (PGF) receptors in smooth muscle, particularly in the uterus.
          </p>
          <ul>
            <li>Stimulates <strong>strong uterine contractions</strong> and increases uterine tone.</li>
            <li>Causes vasoconstriction of uterine blood vessels, helping to reduce bleeding and control PPH.</li>
            <li>Acts on bronchial smooth muscle → may cause <strong>bronchoconstriction</strong>.</li>
            <li>Acts on gastrointestinal smooth muscle → can lead to <strong>vomiting and diarrhea</strong>.</li>
          </ul>
        </div>
        <div>
          <div class="badge-list">
            <span class="badge">↑ Uterine contractility</span>
            <span class="badge">↑ Uterine tone</span>
            <span class="badge">↓ Uterine blood loss</span>
            <span class="badge">Bronchoconstriction</span>
            <span class="badge">GI smooth muscle stimulation</span>
          </div>
          <p class="note" style="margin-top:10px;">
            Primary therapeutic effect: <strong>uterotonic action</strong> for control of PPH and facilitation of mid-trimester termination.
          </p>
        </div>
      </div>
    </section>

    <!-- INTERACTIONS + ADR -->
    <div class="layout">

      <!-- DRUG INTERACTIONS -->
      <section class="card">
        <div class="card-header">
          <h2 class="card-title">Important Drug Interactions</h2>
          <span class="pill">Use with caution</span>
        </div>
        <ul class="interaction-list">
          <li>
            <strong>Other uterotonics</strong> (oxytocin, methylergometrine):  
            ↑ risk of <strong>hypertonic uterus</strong> and <strong>uterine rupture</strong>.
          </li>
          <li>
            <strong>Antihypertensives</strong>:  
            Blood pressure may fluctuate; prostaglandins may reduce antihypertensive effect.
          </li>
          <li>
            <strong>Bronchodilators (β<sub>2</sub>-agonists)</strong>:  
            Opposing actions – bronchodilators relax bronchial smooth muscle, while carboprost causes bronchoconstriction.
          </li>
          <li>
            <strong>Magnesium sulfate</strong>:  
            Slight decrease in uterotonic effect.
          </li>
        </ul>
      </section>

      <!-- ADVERSE EFFECTS -->
      <section class="card">
        <div class="card-header">
          <h2 class="card-title">Adverse Drug Reactions</h2>
          <span class="pill">Monitor closely</span>
        </div>

        <div class="adr-columns">
          <div>
            <div class="chip-title">Common</div>
            <ul>
              <li>Nausea, vomiting</li>
              <li>Diarrhea</li>
              <li>Abdominal cramps</li>
              <li>Fever, chills</li>
              <li>Flushing</li>
            </ul>
          </div>
          <div>
            <div class="chip-title danger">Serious / Important</div>
            <ul>
              <li>Bronchospasm, bronchoconstriction  
                <span class="note">(contraindicated in asthma)</span>
              </li>
              <li>Hypertension</li>
              <li>Tachycardia</li>
              <li>Pulmonary edema</li>
              <li>Uterine hyperstimulation</li>
              <li>Anaphylactoid reaction</li>
            </ul>
          </div>
        </div>

        <div class="warning-strip">
          <div class="warning-icon">⚠️</div>
          <div>
            <strong>Key safety note:</strong> Carboprost should be used only in a monitored setting with resuscitation facilities
            available. Avoid use in patients with asthma or significant cardiopulmonary disease.
          </div>
        </div>
      </section>

    </div>

    <footer>
      This page is for educational / demonstration purposes only and is not a substitute for official prescribing information
      or specialist medical guidance.
    </footer>

  </div>
</body>
</html>

